Leiomyosarcoma Research, Support & Advocacy | LMSDR
The foundation has hosted leiomyosarcoma conferences for patients and professionals.
Leiomyosarcoma Research, Support & Advocacy | LMSDR is a 501(c)(3) nonprofit dedicated to supporting patients, caregivers, and researchers working on treatments for leiomyosarcoma. The organization, established in 2006, offers educational conferences, patient education, support groups, advocacy campaigns, and collaborative research grants. It also maintains a tissue and data collection program and an independent Leiomyosarcoma Patient Registry to aid clinical research.
Academic conference attendance enhances knowledge sharing, fosters multidisciplinary collaboration, and accelerates the translation of research findings into clinical practice.
Bizonyítékszint: Megerősített klinikai bizonyíték. Több vagy erősebb humán vizsgálat támogatja.
Kapcsolódó jelek
- First-Line Chemotherapy Regimens for Advanced and Metastatic Leiomyosarcoma: Doxorubicin vs. Gemcitabine—A Systematic Review
- Leiomyosarcoma
- Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study
- Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival
- Immunotherapy-based salvage therapy in advanced soft tissue sarcoma after first-line chemotherapy: a retrospective single-center analysis with emphasis on undifferentiated pleomorphic sarcoma